TSC-204-A0201
TSCAN-002
Phase 1 mab active
Quick answer
TSC-204-A0201 for Head and Neck Cancer is a Phase 1 program (mab) at TScan Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TScan Therapeutics
- Indication
- Head and Neck Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- active